• /

群馬大学 生体調節研究所

アクセス アクセス

Integrative Metabolic Regulation

Professor: HATTORI Naoko
naoko.hattori*gunma-u.ac.jp
(*=@)
Lab Homepage
https://metabolic-system.imcr.gunma-u.ac.jp/laboratory-of-integrative-metabolic-regulation/

Member

Professor: HATTORI Naoko
Assistant Professor: YAMAGISHI Genki
Technical Officer: TOBO Masayuki
Technical Assistant: IZAWA Yumi
Undergraduate student : CHINO Fumika
Undergraduate student: KIMURA Kozue

Professor: HATTORI Naoko Assistant Professor: YAMAGISHI Genki Technical Officer: TOBO MasayukiProfessor: HATTORI Naoko Assistant Professor: YAMAGISHI Genki Technical Officer: TOBO MasayukiProfessor: HATTORI Naoko Assistant Professor: YAMAGISHI Genki Technical Officer: TOBO Masayuki●1307113071

Research

Dysregulation of cell identity leads to disruption of homeostasis, becoming an underlying cause of disease development. We focus on epigenetics and immune cell signaling, which play crucial roles in cell fate determination, and aim to unravel the pathological mechanisms underlying various diseases, including diabetes, cancer, and allergies. Through an integrative analysis of molecules, cultured cells, and mouse models, we are investigating the molecular basis of disease onset and developing novel therapeutic strategies.

 

On-going projects

  1. Identification of epigenome alterations involved in disease onset and development of epigenetic therapy
  2. Regulation of drug sensitivity by fatty acid metabolism through alterations in cellular membrane composition
  3. Clarification of novel mechanisms of allergic immune responses
  4. Regulation of GDF3-ALK7 axis and fat accumulation by the immune system

Keywords

Epigenetics, immune cells, obesity/diabetes, cancer, allergy, cell membrane

Select References

  1. Okunishi K, et al. (2024) Allergy Online ahead of print. doi: 10.1111/all.16087.
  2. Zhao M*, Okunishi K*, et al. (2023) JCI insight 8(4):e161229. doi: 10.1172/jci.insight.161229.
  3. Hattori N, et al. (2021) Br J Cancer 125(12):1647-1656. doi: 10.1038/s41416-021-01571-y.
  4. Okunishi K, et al. (2020) J Clin Invest 130(7):3919-3935. doi: 10.1172/JCI127839.
  5. Zong L*, Hattori N*, et al. (2019) Oncogene 38(26):5281-5293. doi: 10.1038/s41388-019-0792-8.
  6. Bu Y, Okunishi K, et al. (2018) Diabetes 67:1761-1772. doi: 10.2337/db17-1201.
  7. Hattori N, et al (2013) Nucleic Acids Res 41:7231-7239. doi: 10.1093/nar/gkt528.

PAGE TOP